TickerFacts.

Indivior Pharmaceuticals, Inc. (INDV): Share Repurchases

Annual figures by period end, from SEC filings.

$11.00M
Year ended 2025-12-31
$302.00M
Trailing 12 months to 2026-06-30
-50.4%
3-year compound annual growth
$173.00M2022-12-31: $90.00M2023-12-31: $33.00M2024-12-31: $173.00M2025-12-31: $11.00M$11.00M
2022-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$11.00M-93.6%2026-02-26, From 2025-01-01
2024-12-31$173.00M+424.2%2026-02-26, From 2024-01-01
2023-12-31$33.00M-63.3%2026-02-26, From 2023-01-01
2022-12-31$90.00Mn/a2025-03-03, From 2022-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Indivior Pharmaceuticals, Inc. (INDV)2025-12-31$11.00M-93.6%
Prestige Consumer Healthcare Inc. (PBH)2026-03-31$156.28M+203.4%
Alkermes plc. (ALKS)2024-12-31$200.28Mn/a
ANI Pharmaceuticals Inc (ANIP)2025-12-31$12.21M+11.4%
Collegium Pharmaceutical, Inc (COLL)2025-12-31$25.10M-58.2%
Corcept Therapeutics Inc (CORT)2025-12-31$172.91Mn/m
Emergent BioSolutions Inc. (EBS)2025-12-31$24.90Mn/a
Pacira BioSciences, Inc. (PCRX)2025-12-31$148.33M+493.3%
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$75.59M-11.6%

Compare INDV, PBH, ALKS, ANIP side by side · Screen every company in Pharmaceutical Preparations ↗